These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

352 related articles for article (PubMed ID: 38022646)

  • 1. NK cell exhaustion in the tumor microenvironment.
    Jia H; Yang H; Xiong H; Luo KQ
    Front Immunol; 2023; 14():1303605. PubMed ID: 38022646
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mechanism of tumor cells escaping from immune surveillance of NK cells.
    Ge Z; Wu S; Zhang Z; Ding S
    Immunopharmacol Immunotoxicol; 2020 Jun; 42(3):187-198. PubMed ID: 32223464
    [TBL] [Abstract][Full Text] [Related]  

  • 3. NK Cells in a
    Lee EHC; Wong DCP; Ding JL
    Front Immunol; 2021; 12():734551. PubMed ID: 34594338
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tumor-infiltrating gamma delta T-cells reveal exhausted subsets with remarkable heterogeneity in colorectal cancer.
    Yu L; Wang Z; Hu Y; Wang Y; Lu N; Zhang C
    Int J Cancer; 2023 Nov; 153(9):1684-1697. PubMed ID: 37531161
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cytokines Orchestrating the Natural Killer-Myeloid Cell Crosstalk in the Tumor Microenvironment: Implications for Natural Killer Cell-Based Cancer Immunotherapy.
    Gaggero S; Witt K; Carlsten M; Mitra S
    Front Immunol; 2020; 11():621225. PubMed ID: 33584718
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Functional and metabolic targeting of natural killer cells to solid tumors.
    Wang J; Matosevic S
    Cell Oncol (Dordr); 2020 Aug; 43(4):577-600. PubMed ID: 32488848
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Natural killer cell dysfunction in cancer and new strategies to utilize NK cell potential for cancer immunotherapy.
    Zhang W; Zhao Z; Li F
    Mol Immunol; 2022 Apr; 144():58-70. PubMed ID: 35203022
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeting immune checkpoints: how to use natural killer cells for fighting against solid tumors.
    Ghaedrahmati F; Esmaeil N; Abbaspour M
    Cancer Commun (Lond); 2023 Feb; 43(2):177-213. PubMed ID: 36585761
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Challenges and Recent Advances in NK Cell-Targeted Immunotherapies in Solid Tumors.
    Lian G; Mak TS; Yu X; Lan HY
    Int J Mol Sci; 2021 Dec; 23(1):. PubMed ID: 35008589
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeting Natural Killer Cells for Tumor Immunotherapy.
    Zhang C; Hu Y; Shi C
    Front Immunol; 2020; 11():60. PubMed ID: 32140153
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Modulation of natural killer cell exhaustion in the lungs: the key components from lung microenvironment and lung tumor microenvironment.
    Zhang H; Wang J; Li F
    Front Immunol; 2023; 14():1286986. PubMed ID: 38022613
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Unleashing Natural Killer Cells in the Tumor Microenvironment-The Next Generation of Immunotherapy?
    Ben-Shmuel A; Biber G; Barda-Saad M
    Front Immunol; 2020; 11():275. PubMed ID: 32153582
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Natural Killer Cell Interactions With Myeloid Derived Suppressor Cells in the Tumor Microenvironment and Implications for Cancer Immunotherapy.
    Zalfa C; Paust S
    Front Immunol; 2021; 12():633205. PubMed ID: 34025641
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Underlying mechanisms of evasion from NK cells as rationale for improvement of NK cell-based immunotherapies.
    Seliger B; Koehl U
    Front Immunol; 2022; 13():910595. PubMed ID: 36045670
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Advances in metabolic reprogramming of NK cells in the tumor microenvironment on the impact of NK therapy.
    Miao L; Lu C; Zhang B; Li H; Zhao X; Chen H; Liu Y; Cui X
    J Transl Med; 2024 Mar; 22(1):229. PubMed ID: 38433193
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acquired Natural Killer Cell Dysfunction in the Tumor Microenvironment of Classic Hodgkin Lymphoma.
    Chiu J; Ernst DM; Keating A
    Front Immunol; 2018; 9():267. PubMed ID: 29491867
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Natural killer cell-based strategies for immunotherapy of cancer.
    Vaněk O; Kalousková B; Abreu C; Nejadebrahim S; Skořepa O
    Adv Protein Chem Struct Biol; 2022; 129():91-133. PubMed ID: 35305726
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization and Manipulation of the Crosstalk Between Dendritic and Natural Killer Cells Within the Tumor Microenvironment.
    Jacobs B; Gebel V; Heger L; Grèze V; Schild H; Dudziak D; Ullrich E
    Front Immunol; 2021; 12():670540. PubMed ID: 34054844
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metabolic adaptations determine whether natural killer cells fail or thrive within the tumor microenvironment.
    Moinuddin A; Poznanski SM; Portillo AL; Monteiro JK; Ashkar AA
    Immunol Rev; 2024 May; 323(1):19-39. PubMed ID: 38459782
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Remodeled tumor immune microenvironment (TIME) parade via natural killer cells reprogramming in breast cancer.
    Elanany MM; Mostafa D; Hamdy NM
    Life Sci; 2023 Oct; 330():121997. PubMed ID: 37536617
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.